Literature DB >> 21832998

Chronic kidney disease, 24-h blood pressure and small vessel diseases are independently associated with cognitive impairment in lacunar infarct patients.

Yasumasa Yamamoto1, Tomoyuki Ohara, Yoshinari Nagakane, Eijiro Tanaka, Fukiko Morii, Takashi Koizumi, Ichiro Akiguchi.   

Abstract

Although the relationships between chronic kidney disease (CKD) and cognitive impairment (CI) have been highlighted, the etiology of CI in CKD remains uncertain. Subjects comprised 224 consecutive patients with symptomatic lacunar infarction who underwent magnetic resonance imaging and ambulatory blood pressure monitoring (ABPM). Diurnal blood pressure (BP) patterns were categorized into three groups: dippers, non-dippers and risers. Lacunar infarcts (LIs), including both symptomatic and silent and diffuse white matter lesions (WMLs), were graded into three grades according to their degree. The results of kidney function were evaluated using estimated glomerular filtration rate (eGFR), categorized into three groups: stage 1, >60; stage 2, 30-60; and stage 3, <30 ml min(-1) per 1.73 m(2). There were 44 patients with CI. Confluent WMLs, including WML 2 and WML 3, were found in 36 patients (81.8%), and multiple lacunae including LI 2 and LI 3 were found in 30 patients (68.1%) with CI. Age >75 years (odds ratio (OR), 5.5; P<0.05), male sex (OR, 2.8; P<0.05), non-dippers (OR, 6.3; P<0.05) and risers (OR, 5.6; P<0.05), eGFR 30-60 ml min(-1) per 1.73 m(2) (OR, 2.9; P<0.05) and eGFR <30 ml min(-1) per 1.73 m(2) (OR, 23.8; P<0.01), WML grade 2 (OR, 5.1; P<0.01) and WML grade 3 (OR, 45.2; P<0.001) and LI grade 2 (OR, 3.2; P<0.05) and LI grade 3 (OR, 6.4; P<0.05) were independently associated with CI. Age >75 years (OR, 4.1; P<0.05), eGFR 30-60 ml min(-1) per 1.73 m(2) (OR, 3.7; P<0.05) and eGFR <30 ml min(-1) per 1.73 m(2) (OR, 8.7; P<0.05) were independently associated with WML grade 3. Extensive small vessel diseases, CKD and non-dipping status were independently associated with CI. CKD appears to mainly contribute to vascular CI, whereas possibilities of overlapping with other mechanisms such as degenerative CI cannot be excluded. Strict night time BP control and renoprotective treatment may be warranted to prevent CI.

Entities:  

Mesh:

Year:  2011        PMID: 21832998     DOI: 10.1038/hr.2011.118

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  13 in total

1.  High Circulatory Phosphate Level Is Associated with Cerebral Small-Vessel Diseases.

Authors:  Chih-Ping Chung; Li-Ning Peng; Kun-Hsien Chou; Li-Kuo Liu; Wei-Ju Lee; Ching-Po Lin; Liang-Kung Chen; Pei-Ning Wang
Journal:  Transl Stroke Res       Date:  2018-06-25       Impact factor: 6.829

2.  Fiber connectivity density mapping in end-stage renal disease patients: a preliminary study.

Authors:  Chi Ma; Xinghai Jiang; Yande Ren; Gaojie Gu; Airong Fu; Chengjian Wang; Peirui Bai; Tong Zhou; Shanshan Qin; Shengli Fu
Journal:  Brain Imaging Behav       Date:  2022-01-09       Impact factor: 3.978

3.  Should an elderly patient with stage V CKD and dementia be started on dialysis?

Authors:  Irene Ying; Zoe Levitt; Sarbjit Vanita Jassal
Journal:  Clin J Am Soc Nephrol       Date:  2013-11-14       Impact factor: 8.237

4.  Association between physical performance and all-cause mortality in CKD.

Authors:  Baback Roshanravan; Cassianne Robinson-Cohen; Kushang V Patel; Ernest Ayers; Alyson J Littman; Ian H de Boer; T Alp Ikizler; Jonathan Himmelfarb; Leslie I Katzel; Bryan Kestenbaum; Stephen Seliger
Journal:  J Am Soc Nephrol       Date:  2013-04-18       Impact factor: 10.121

5.  Hyperbaric area index calculated from ABPM elucidates the condition of CKD patients: the CKD-JAC study.

Authors:  Satoshi Iimuro; Enyu Imai; Tsuyoshi Watanabe; Kosaku Nitta; Tadao Akizawa; Seiichi Matsuo; Hirofumi Makino; Yasuo Ohashi; Akira Hishida
Journal:  Clin Exp Nephrol       Date:  2014-03-30       Impact factor: 2.801

Review 6.  Chronic Management of Hypertension after Stroke: The Role of Ambulatory Blood Pressure Monitoring.

Authors:  Luis Castilla-Guerra; Maria Del Carmen Fernandez-Moreno
Journal:  J Stroke       Date:  2015-12-17       Impact factor: 6.967

7.  The relationship between ambulatory blood pressure variability and enlarged perivascular spaces: a cross-sectional study.

Authors:  Shuna Yang; Wei Qin; Lei Yang; Huimin Fan; Yue Li; Jiangmei Yin; Wenli Hu
Journal:  BMJ Open       Date:  2017-08-21       Impact factor: 2.692

8.  Plasma homocysteine and cerebral small vessel disease as possible mediators between kidney and cognitive functions in patients with diabetes mellitus.

Authors:  Mika Sonoda; Tetsuo Shoji; Yukinobu Kuwamura; Yujiro Okute; Toshihide Naganuma; Hideaki Shima; Koka Motoyama; Tomoaki Morioka; Katsuhito Mori; Shinya Fukumoto; Atsushi Shioi; Taro Shimono; Hisako Fujii; Daijiro Kabata; Ayumi Shintani; Masanori Emoto; Masaaki Inaba
Journal:  Sci Rep       Date:  2017-06-29       Impact factor: 4.379

9.  Impact of Circadian Blood Pressure Pattern on Silent Cerebral Small Vessel Disease: A Systematic Review and Meta-Analysis.

Authors:  Anthipa Chokesuwattanaskul; Wisit Cheungpasitporn; Charat Thongprayoon; Saraschandra Vallabhajosyula; Tarun Bathini; Michael A Mao; Liam D Cato; Ronpichai Chokesuwattanaskul
Journal:  J Am Heart Assoc       Date:  2020-06-01       Impact factor: 5.501

10.  MRI features of Binswanger's disease predict prognosis and associated pathology.

Authors:  Ichiro Akiguchi; Herbert Budka; Yoshitomo Shirakashi; Adelheid Woehrer; Toshiyuki Watanabe; Akihiko Shiino; Yasumasa Yamamoto; Yasuhiro Kawamoto; Wolfgang Krampla; Susanne Jungwirth; Peter Fischer
Journal:  Ann Clin Transl Neurol       Date:  2014-10-06       Impact factor: 4.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.